Abstract
Nitric oxide (NO) is a novel neuronal messenger molecule which can mediate rapid signaling, diffusing freely in three dimensions to act throughout local regions of neural tissue (Garthwaite and Boulton 1995; Yun et al. 1996). NO and other nitrogen oxides are derived from chemical reactions following NOS activation. NO production can regulate ion channel activity, neurotransmitter release, cerebral blood flow, synaptic plasticity, growth cone structure, and gene expression in the nervous system. NO can elicit such diverse cellular signaling due to a wide variety of molecular targets including soluble guanylate cyclase, other heme-containing enzymes including cyclooxygenase, thiol moieties and tyrosine residues on proteins, iron sulfur-containing proteins, and superoxide anion. Thus, NO is important in normal neuronal signaling; however, when NO production is unregulated or excessive, NO can mediate neuronal degeneration. NO has been implicated in the neuropathology of stroke, trauma, AIDS dementia, Alzheimer’s disease, multiple sclerosis, as well as bacterial and viral encephalitis (Dawson and Snyder 1994; Meldrum 1996). Limiting NO production under pathologic conditions has become a potentially important therapeutic target for the treatment of various neurologic diseases and disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abu-Soud HM, Feldman PL, Clark P, Stuehr DJ (1994) Electron transfer in the nitric-oxide synthases. Characterization of L-arginine analogs that block heme iron reduction. J Biol Chem 269: 32318–32326
Adamson DC, Kopnisky KL, Dawson TM, Dawson VL (1999) Mechanisms and Structural Determinants of HIV-1 Coat Protein gp41-Induced Neurotoxicity. J Neurosci 19: 64–71
Adamson DC, McArthur JC, Dawson TM, Dawson VL (1999) Course of HIV-Associated Dementia: Correlations with gp41, iNOS and Macrophage/Microglial Activation. Mol Med in press:
Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL (1996) Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274: 1917–1921
Arkovitz MS, Wispe JR, Garcia VF, Szabo C (1996) Selective inhibition of the inducible isoform of nitric oxide synthase prevents pulmonary transvascular flux during acute endotoxemia. J Pediatr Surg 31: 1009–1015
Babbedge RC, Bland-Ward PA, Hart SL, Moore PK (1993) Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol 110: 225–228
Babu BR, Griffith OW (1998) N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase. J Biol Chem 273: 8882–8889
Berka V, Palmer G, Chen PF, Tsai AL (1998) Effects of various imidazole ligands on heme conformation in endothelial nitric oxide synthase. Biochemistry 37: 6136–6144
Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36: 778–786
Bredt DS, Ferris CD, Snyder SH (1992) Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J Biol Chem 267: 10976–10981
Bredt DS, Hwang PM, Snyder SH (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347: 768–770
Bredt DS, Snyder SH (1994) Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63: 175–195
Brenman JE, Christopherson KS, Craven SE, McGee AW, Bredt DS (1996) Cloning and characterization of postsynaptic density 93, a nitric oxide synthase interacting protein. J Neurosci 16: 7407–7415
Bune AJ, Brand MP, Heales SJ, Shergill JK, Cammack R, Cook HT (1996) Inhibition of tetrahydrobiopterin synthesis reduces in vivo nitric oxide production in experimental endotoxic shock. Biochem Biophys Res Commun 220: 13–19
Caggiano AO, Kraig RP (1998) Neuronal nitric oxide synthase expression is induced in neocortical astrocytes after spreading depression. J Cereb Blood Flow Metab 18: 75–87
Chalimoniuk M, Glód B, Strosznajder J (1996) NMDA receptor mediated nitric oxide dependent cGMP synthesis in brain cortex and hippocampus. Effect of ischemia on NO related biochemical processes during reperfusion. Neurologia I Neurochirurgia Polska 30 Suppl 2: 65–84
Chalimoniuk M, Strosznajder J (1998) NMDA receptor-dependent nitric oxide and cGMP synthesis in brain hemispheres and cerebellum during reperfusion after transient forebrain ischemia in gerbils: effect of 7-Nitroindazole. Journal Of Neuroscience Research 54: 681–690
Chan MM, Fong D, Ho CT, Huang HI (1997) Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem Pharmacol 54: 1281–1286
Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623–634
Coeroli L, Renolleau S, Arnaud S, Plotkine D, Cachin N, Plotkine M, Ben-Ari Y, Charriaut-Marlangue C (1998) Nitric oxide production and perivascular tyrosine nitration following focal ischemia in neonatal rat. J Neurochem 70: 2516–2525
Coert BA, Anderson RE, Meyer FB (1999) A comparative study of the effects of two nitric oxide synthase inhibitors and two nitric oxide donors on temporary focal cerebral ischemia in the Wistar rat. Journal Of Neurosurgery 90: 332–338
Cowden WB, Cullen FA, Staykova MA, Willenborg DO (1998) Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J Neuroimmunol 88: 1–8
Craven SE, Bredt DS (1998) PDZ proteins organize synaptic signaling pathways. Cell 93: 495–498
Dalkara T, Yoshida T, Irikura K, Moskowitz MA (1994) Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology 33: 1447–1452
Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH (1991) Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA 88: 7797–7801
Dawson TM, Snyder SH (1994) Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 14: 5147–5159
Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH (1993) Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci. USA 90: 9808–9812
Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 13: 2651–2661
Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proceedings of the National Academy of Sciences of the United States of America 88: 6368–6371
Dawson VL, Kizushi VM, Huang PL, Snyder SH, Dawson TM (1996) Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci 16: 2479–2487
Dick JM, Lefebvre RA (1997) Influence of different classes of NO synthase inhibitors in the pig gastric fundus. Naunyn Schmiedebergs Arch Pharmacol 356: 488–494
Dinerman JL, Dawson TM, Schell MJ, Snowman A, Snyder SH (1994) Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc Natl Acad Sci USA 91: 4214–4218
Dinerman JL, Steiner JP, Dawson TM, Dawson V, Snyder SH (1994) Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology 33: 1245–1251
Doddo JM, Zheng G, Silverman HS, Lakatta EG, Ziegelstein RC (1997) Endothelium-independent relaxation of aortic rings by the nitric oxide synthase inhibitor diphenyleneiodonium. Br J Pharmacol 120: 857–864
Doyle CA, Slater P (1997) Localization of neuronal and endothelial nitric oxide synthase isoforms in human hippocampus. Neuroscience 76: 387–395
Dreier JP, Korner K, Ebert N, Gorner A, Rubin I, Back T, Lindauer U, Wolf T, Villringer A, Einhaupl KM, Lauritzen M, Dirnagl U (1998) Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab 18: 978–990
Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95: 8880–8885
Epstein LG, Gendelman HE (1993) Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 33: 429–436
Escott KJ, Beech JS, Haga KK, Williams SC, Meldrum BS, Bath PM (1998) Cere-broprotective effect of the nitric oxide synthase inhibitors, 1-(2-trifluo-romethylphenyl) imidazole and 7-nitro indazole, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 18: 281–287
Fenyk-Melody JE, Garrison AE, Brunnert SR, Weidner JR, Shen F, Shelton BA, Mudgett JS (1998) Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J Immunol 160: 2940–2946
Ferrante RJ, Kowall NW, Beal MF, Richardson EP, Jr, Bird ED, Martin JB (1985) Selective sparing of a class of striatal neurons in Huntington’s disease. Science 230: 561–563
Garthwaite J, Boulton CL (1995) Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57: 683–706
Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, et al. (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176: 1703–1718
Gillardon F, Krep H, Brinker G, Lenz C, Bottiger B, Hossmann KA (1998) Induction of protein inhibitor of neuronal nitric oxide synthase/cytoplasmic dynein light chain following cerebral ischemia. Neuroscience 84: 81–88
Gonzalez-Zulueta M, Ensz LM, Mukhina G, Lebovitz RM, Zwacka RM, Engelhardt JF, Oberley LW, Dawson VL, Dawson TM (1998) Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J Neurosci 18: 2040–2055
Grandati M, Verrecchia C, Revaud ML, Allix M, Boulu RG, Plotkine M (1997) Calcium-independent NO-synthase activity and nitrites/nitrates production in transient focal cerebral ischaemia in mice. Br J Pharmacol 122: 625–630
Handy RL, Harb HL, Wallace P, Gaffen Z, Whitehead KJ, Moore PK (1996) Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects. Br J Pharmacol 119: 423–431
Handy RL, Moore PK (1997) Mechanism of the inhibition of neuronal nitric oxide synthase by 1-(2- trifluoromethylphenyl) imidazole (TRIM). Life Sci 60: PL389–394
Handy RL, Moore PK (1998) A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. Br J Pharmacol 123: 1119–1126
Handy RL, Wallace P, Gaffen ZA, Whitehead KJ, Moore PK (1995) The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br J Pharmacol 116: 2349–2350
Hansen DW, Jr, Peterson KB, Trivedi M, Kramer SW, Webber RK, Tjoeng FS, Moore WM, Jerome GM, Kornmeier CM, Manning PT, Connor JR, Misko TP, Currie MG, Pitzele BS (1998) 2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS). J Med Chem 41: 1361–1366
Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Matthews RT, Beal MF (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Medicine 2: 1017–1021
Higuchi Y, Hattori H, Kume T, Tsuji M, Akaike A, Furusho K (1998) Increase in nitric oxide in the hypoxic-ischemic neonatal rat brain and suppression by 7-nitroindazole and aminoguanidine. Eur J Pharmacol 342: 47–49
Hrabak A, Bajor T, Southan GJ, Salzman AL, Szabo C (1997) Comparison of the inhibitory effect of isothiourea and mercapto- alkylguanidine derivatives on the alternative pathways of arginine metabolism in macrophages. Life Sci 60: PL395–401
Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase . Nature 377: 239–242
Hyman BT, Marzloff K, Wenniger JJ, Dawson TM, Bredt DS, Snyder SH (1992) Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer’s disease. Ann Neurol 32: 818–820
Iadecola C (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20: 132–139
Jaffrey SR, Snowman AM, Eliasson MJ, Cohen NA, Snyder SH (1998) CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron 20: 115–124
Jaffrey SR, Snyder SH (1996) PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science 274: 774–777
Jang D, Szabo C, Murrell GA (1996) S-substituted isothioureas are potent inhibitors of nitric oxide biosynthesis in cartilage. Eur J Pharmacol 312: 341–347
Kabuto H, Yokoi I, Habu H, Asahara H, Mori A (1995) Inhibitory effect of arcaine on nitric oxide synthase in the rat brain. Neuroreport 6: 554–556
Kamii H, Mikawa S, Murakami K, Kinouchi H, Yoshimoto T, Reola L, Carlson E, Epstein CJ, Chan PH (1996) Effects of nitric oxide synthase inhibition on brain infarction in SOD-1-transgenic mice following transient focal cerebral ischemia. Journal Of Cerebral Blood Flow And Metabolism 16: 1153–1157
Kantor DB, Lanzrein M, Stary SJ, Sandoval GM, Smith WB, Sullivan BM, Davidson N, Schuman EM (1996) A role for endothelial NO synthase in LTP revealed by adenovirus-mediated inhibition and rescue. Science 274: 1744–1748
Kilbourn RG, Griffith OW (1992) Inhibition of inducible nitric oxide synthase with inhibitors of tetrahydrobiopterin biosynthesis. J Natl Cancer Inst 84: 1672
Kinoshita H, Milstien S, Wambi C, Katusic ZS (1997) Inhibition of tetrahydrobiopterin biosynthesis impairs endothelium-dependent relaxations in canine basilar artery. Am J Physiol 273: H718-H724
Klatt P, Schmid M, Leopold E, Schmidt K, Werner ER, Mayer B (1994) The pteridine binding site of brain nitric oxide synthase. Tetrahydrobiopterin binding kinetics, specificity, allosteric interaction with the substrate domain. J Biol Chem 269: 13861–13866
Koh JY, Choi DW (1988) Cultured striatal neurons containing NADPH-diaphorase or acetylcholinesterase are selectively resistant to injury by NMDA receptor agonists. Brain Res 446: 374–378
Koh JY, Peters S, Choi DW (1986) Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity. Science 234: 73–76
Kumagai Y, Nakajima H, Midorikawa K, Homma-Takeda S, Shimojo N (1998) Inhibition of nitric oxide formation by neuronal nitric oxide synthase by quinones: nitric oxide synthase as a quinone reductase. Chem Res Toxicol 11: 608–613
Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ (1993) Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 90: 9730–9734
Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH (1992) Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proceedings of the National Academy of Sciences of the United States of America 89: 6711–6715
Lyons CR, Orloff GJ, Cunningham JM (1992) Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267: 6370–6374
MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA (1996) Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 93: 11853–11858
Marietta MA (1994) Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78: 927–930
Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T (1992) Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 307: 287–293
Mayer B, John M, Heinzel B, Werner ER, Wachter H, Schultz G, Bohme E (1991) Brain nitric oxide synthase is a biopterin- and flavin-containing multi functional oxido-reductase. FEBS Lett 288: 187–191
Mayer B, Klatt P, Werner ER, Schmidt K (1994) Molecular mechanisms of inhibition of porcine brain nitric oxide synthase by the antinociceptive drug 7-nitro-indazole. Neuropharmacology 33: 1253–1259
Mayer B, Werner ER (1995) In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide. Naunyn Schmiedebergs Arch Pharmacol 351: 453–463
Meldrum BS (1996) The role of nitric oxide in ischemic damage. Adv Neurol 71: 355–363
Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151: 2132–2141
Moncada S, Higgs EA (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide . Faseb J 9: 1319–1330
Moore PK, Wallace P, Gaffen Z, Hart SL, Babbedge RC (1993) Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol 110: 219–224
Morris HR, Etienne AT, Panico M, Tippins JR, Alaghband-Zadeh J, Holland SM, Mehdizadeh S, de Belleroche J, Das I, Khan NS, de Wardener HE (1997) Hypothalamic hypertensive factor: an inhibitor of nitric oxide synthase activity. Hypertension 30: 1493–1498
Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, Reis DJ, Minc-Golomb D, Schwartz JP (1993) Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 16: 323–328
Nagayama M, Zhang F, Iadecola C (1998) Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. J Cereb Blood Flow Metab 18: 1107–1113
Nanri K, Montecot C, Springhetti V, Seylaz J, Pinard E (1998) The selective inhibitor of neuronal nitric oxide synthase, 7-nitroindazole, reduces the delayed neuronal damage due to forebrain ischemia in rats. Stroke 29: 1248–53; discussion 1253–1254
Narayanan K, Spack L, McMillan K, Kilbourn RG, Hayward MA, Masters BS, Griffith OW (1995) S-alkyl-L-thiocitrullines. Potent stereoselective inhibitors of nitric oxide synthase with strong pressor activity in vivo. J Biol Chem 270: 11103–11110
Navia BA, Jordan BD, Price RW (1986) The AIDS dementia complex: I. Clinical features. Ann Neurol 19: 517–524
Nowicki JP, Duval D, Poignet H, Scatton B (1991) Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol 204: 339–340
Okuda Y, Sakoda S, Fujimura H, Yanagihara T (1998) Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase. J Neuroimmunol 81: 201–210
Onitsuka M, Mihara S, Yamamoto S, Shigemori M, Higashi H (1998) Nitric oxide contributes to irreversible membrane dysfunction caused by experimental ischemia in rat hippocampal CA1 neurons. Neurosci Res 30: 7–12
Pfeiffer S, Gorren AC, Pitters E, Schmidt K, Werner ER, Mayer B (1997) Allosteric modulation of rat brain nitric oxide synthase by the pterin- site enzyme inhibitor 4-aminotetrahydrobiopterin. Biochem J 328: 349–352
Price RW (1996) Neurological complications of HIV infection. Lancet 348: 445–452
Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 93: 4565–4571
Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ, Cadet JL (1992) Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci 12: 1658–1667
Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288: 481–487
Resink AM, Dawson VL, Dawson TM (1996) Nitric Oxide Inhibitors: Future Therapies for CNS Disorders. CNS Drugs Review 6: 351–357
Robbins RA, Jinkins PA, Bryan TW, Prado SC, Milligan SA (1998) Methotrexate inhibition of inducible nitric oxide synthase in murine lung epithelial cells in vitro. Am J Respir Cell Mol Biol 18: 853–859
Rosselet A, Feihl F, Markert M, Gnaegi A, Perret C, Liaudet L (1998) Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock. Am J Respir Crit Care Med 157: 162–170
Ruan J, Xie Q, Hutchinson N, Cho H, Wolfe GC, Nathan C (1996) Inducible nitric oxide synthase requires both the canonical calmodulin- binding domain and additional sequences in order to bind calmodulin and produce nitric oxide in the absence of free Ca2+. J Biol Chem 271: 22679–22686
Ruetten H, Southan GJ, Abate A, Thiemermann C (1996) Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br J Pharmacol 118: 261–270
Saetre T, Gundersen Y, Thiemermann C, Lilleaasen P, Aasen AO (1998) Aminoethylisothiourea, a selective inhibitor of inducible nitric oxide synthase activity, improves liver circulation and oxygen metabolism in a porcine model of endotoxemia. Shock 9: 109–115
Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D, Henshaw DR, Cipolloni PB, Mecocci P, Kowall NW, Rosen BR et al. (1995) Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci 15: 8419–8429
Schulz JB, Matthews RT, Muqit MM, Browne SE, Beal MF (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. Journal of Neurochemistry 64: 936–939
Sharkey J, Butcher SP (1994) Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371: 336–339
Shearer BG, Lee S, Oplinger JA, Frick LW, Garvey EP, Furfine ES (1997) Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity. J Med Chem 40: 1901–1105
Son H, Hawkins RD, Martin K, Kiebler M, Huang PL, Fishman MC, Kandel ER (1996) Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 87: 1015–1023
Stagliano NE, Dietrich WD, Prado R, Green EJ, Busto R (1997) The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat. Brain Research 759: 32–40
Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA, Levi R, Nathan CF (1991) Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. Faseb J 5: 98–103
Szabo C, Bryk R, Zingarelli B, Southan GJ, Gahman TC, Bhat V, Salzman AL, Wolff DJ (1996) Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform. Br J Pharmacol 118: 1659–1668
Thiemermann C, Ruetten H, Wu CC, Vane JR (1995) The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116: 2845–2851
Tokime T, Nozaki K, Sugino T, Kikuchi H, Hashimoto N, Ueda K (1998) Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain. J Cereb Blood Flow Metab 18: 991–997
Toung TJ, Bhardwaj A, Dawson VL, Dawson TM, Traystman RJ, Hum PD (1999) Immunosuppressent FK506 Affords Focal Ischemic Neuroprotection without Altering Nitric Oxide Production In Vivo. Stroke in press
Uemura Y, Kowall NW, Beal MF (1990) Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann Neurol 27: 620–625
Wang YX, Pang CC (1993) Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase. J Pharmacol Exp Ther 265: 263–272
Webber RK, Metz S, Moore WM, Connor JR, Currie MG, Fok KF, Hagen TJ, Hansen DW, Jr, Jerome GM, Manning PT, Pitzele BS, Toth MV, Trivedi M, Zupec ME, Tjoeng FS (1998) Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms. J Med Chem 41: 96–101
Wei J, Quast MJ (1998) Effect of nitric oxide synthase inhibitor on a hyperglycemic rat model of reversible focal ischemia: detection of excitatory amino acids release and hydroxyl radical formation. Brain Res 791: 146–156
Wiley CA, Achim CL (1995) Human immunodeficiency virus encephalitis and dementia. Ann Neurol 38: 559–560
Win NH, Ishikawa T, Saito N, Kato M, Yokokura H, Watanabe Y, Iida Y, Hidaka H (1996) A new and potent calmodulin antagonist, HF-2035; which inhibits vascular relaxation induced by nitric oxide synthase. Eur J Pharmacol 299: 119–126
Wolff DJ, Gauld DS, Neulander MJ, Southan G (1997) Inactivation of nitric oxide synthase by substituted aminoguanidines and aminoisothioureas. J Pharmacol Exp Ther 283: 265–273
Wolff DJ, Lubeskie A (1996) Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine. Arch Biochem Biophys 325: 227–234
Wolff DJ, Naddelman RA, Lubeskie A, Saks DA (1996) Inhibition of nitric oxide synthase isoforms by porphyrins. Arch Biochem Biophys 333: 27–34
Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225–228
Xie QW, Whisnant R, Nathan C (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 177: 1779–1784
Yokoi I, Kabuto H, Habu H, Inada K, Toma J, Mori A (1994) Structure-activity relationships of arginine analogues on nitric oxide synthase activity in the rat brain. Neuropharmacology 33: 1261–1265
Yun HY, Dawson VL, Dawson TM (1996) Neurobiology of nitric oxide. Crit Rev Neurobiol 10: 291–316
Zhang F, Iadecola C (1998) Temporal characteristics of the protective effect of aminoguanidine on cerebral ischemic damage. Brain Res 802: 104–110
Zhang ZG, Reif D, Macdonald J, Tang WX, Kamp DK, Gentile RJ, Shakespeare WC, Murray RJ, Chopp M (1996) ARL 17477; a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 16: 599–604
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sasaki, M., Dawson, T.M., Dawson, V.L. (2002). Blocking Nitric Oxide Toxicity. In: Marcoux, F.W., Choi, D.W. (eds) CNS Neuroprotection. Handbook of Experimental Pharmacology, vol 155. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06274-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-06274-6_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-07625-1
Online ISBN: 978-3-662-06274-6
eBook Packages: Springer Book Archive